title: The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents.
abstract: Strong thrombocytopenia is observed during acute infection with Trypanosoma cruzi, the parasitic protozoan agent of American trypanosomiasis or Chagas' disease. The parasite sheds trans-sialidase, an enzyme able to mobilize the sialyl residues on cell surfaces, which is distributed in blood and is a virulence factor. Since the sialic acid content on the platelet surface is crucial for determining the half-life of platelets in blood, we examined the possible involvement of the parasite-derived enzyme in thrombocytopenia induction. We found that a single intravenous injection of trans-sialidase into naive mice reduced the platelet count by 50%, a transient effect that lasted as long as the enzyme remained in the blood. CD43(-/-) mice were affected to a similar extent. When green fluorescent protein-expressing platelets were treated in vitro with trans-sialidase, their sialic acid content was reduced together with their life span, as determined after transfusion into naive animals. No apparent deleterious effect on the bone marrow was observed. A central role for Kupffer cells in the clearance of trans-sialidase-altered platelets was revealed after phagocyte depletion by administration of clodronate-containing liposomes and splenectomy. Consistent with this, parasite strains known to exhibit more trans-sialidase activity induced heavier thrombocytopenia. Finally, the passive transfer of a trans-sialidase-neutralizing monoclonal antibody to infected animals prevented the clearance of transfused platelets. Results reported here strongly support the hypothesis that the trans-sialidase is the virulence factor that, after depleting the sialic acid content of platelets, induces the accelerated clearance of the platelets that leads to the thrombocytopenia observed during acute Chagas' disease.
authors.affiliation: Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, Predio INTI, Edificio 24, Av. General Paz y Constituyentes, B1650WAB San Martín, Buenos Aires, Argentina.
authors.forename: María Virginia
authors.initials: MV
authors.lastname: Tribulatti
authors.forename: Juan
authors.initials: J
authors.lastname: Mucci
authors.forename: Nico
authors.initials: N
authors.lastname: Van Rooijen
authors.forename: María Susana
authors.initials: MS
authors.lastname: Leguizamón
authors.forename: Oscar
authors.initials: O
authors.lastname: Campetella
mesh_terms: D000208:Acute Disease; D000818:Animals; D015703:Antigens, CD / Q000502:physiology; D001792:Blood Platelets / Q000737:chemistry*; D014355:Chagas Disease / Q000150:complications*; D006023:Glycoproteins; D007728:Kupffer Cells / Q000502:physiology; D051917:Leukosialin; D051379:Mice; D008815:Mice, Inbred Strains; D019158:N-Acetylneuraminic Acid / Q000097:blood*; D009439:Neuraminidase / Q000502:physiology*; D012795:Sialoglycoproteins / Q000502:physiology; D013921:Thrombocytopenia / Q000209:etiology*; D014349:Trypanosoma cruzi / Q000201:enzymology* / Q000472:pathogenicity; D037521:Virulence Factors / Q000502:physiology*
chemical_list: D015703:Antigens, CD; D006023:Glycoproteins; D051917:Leukosialin; D012795:Sialoglycoproteins; C497863:Spn protein, mouse; D037521:Virulence Factors; C069715:trans-sialidase; D009439:Neuraminidase; D019158:N-Acetylneuraminic Acid